MedPath

Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients

Completed
Conditions
Constipation
Diarrhea
Gastrointestinal Disease
Intolerance; Nutritional
Interventions
Other: MDR bacteria positivity
Other: negative fluid balance
Registration Number
NCT04014816
Lead Sponsor
Ayancık State Hospital
Brief Summary

Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable. Our aim is to evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.

Detailed Description

Critical illness is typically associated with a catabolic stress state in which patients demonstrate a systemic inflammatory response coupled with complications of increased infectious morbidity, multiple organ dysfunction, prolonged hospitalization, and disproportionate mortality. Suspension of feeding and the resultant inability to reach nutritional goals is one complication of gastrointestinal (GI) dysfunction, but there are others (mucosal barrier disruption, altered motility, atrophy of the mucosa, and reduced mass of gut-associated lymphoid tissue) that may explain the greater length of stay (LOS) and death rate with GI dysfunction. In Europe and the United States, nutritional administration guidelines recommend primarily enteral nutrition (EN) for hemodynamically stable intensive care unit (ICU) patients. Providing EN in these patients has been shown to be superior to parenteral nutrition. GI complications such as constipation, delayed gastric emptying, diarrhea, and vomiting may occur in up to 50% of mechanically ventilated patients and adversely affect ICU mortality and LOS. Nevertheless, there is no consensus for obtaining a precise assessment of GI function.Diagnosis of GI dysfunction in ICU patients is complex and relies on clinical symptoms. Lack of validated markers of GI system dysfunction is often misdiagnosed and poorly managed in the ICU. The role of nutrition in critical illness is important, but there is an increasing evidence and broadening consensus that aggressive early feeding as well as prolonged underfeeding both should be avoided. Avoidance of complications like malnutrition, aspiration of gastric contents, wound infections, and decubitus through GI dysfunction is an important part of management of patients with GI failure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
137
Inclusion Criteria

Older than 18 years old. Stay longer than 48 hours at ICU.

Exclusion Criteria

Has enterostomy/colostomy or diagnosis of GI bleeding. Prone position. Laxative drug use. Clostridium Difficile infection positivity.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group IMDR bacteria positivityPatients who had GI dysfunction (Group I) for one or more occasions.
Group IIMDR bacteria positivityPatients who had normal GI function (Group II) for one or more occasions.
Group IInegative fluid balancePatients who had normal GI function (Group II) for one or more occasions.
Group Inegative fluid balancePatients who had GI dysfunction (Group I) for one or more occasions.
Primary Outcome Measures
NameTimeMethod
The incidence of GI dysfunctionup to 14 days.

Constipation, diarrhea, UDI

Secondary Outcome Measures
NameTimeMethod
Length of hospital staythrough study completion, which is 6 months time period.

days

Catecholamine useup to 14 days.

mcg

The sequential organ failure assessment(SOFA) scoreat admission.

SOFA Score is a mortality pre-score that is based on the degree of dysfunction of six organ systems. Each organ system is assigned a point value from 0 (normal)to 4 (high degree of dysfunction/failure). The SOFA score ranges from 0 to 24.The highest SOFA score correlates with highest mortality rates. Scores of more than 11 corresponded to mortality of more than 80%.

Hypoalbuminemiaup to 14 days.

below 2,5 g/dl

© Copyright 2025. All Rights Reserved by MedPath